Home > Boards > US Listed > Biotechs > Edesa Biotech, Inc. (EDSA)

I don't visit ihub much, but came back

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Gulo Member Profile
 
Followed By 2
Posts 8
Boards Moderated 0
Alias Born 02/10/02
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 11/22/2021 4:20:25 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/22/2021 4:18:36 PM
ATER, GREE and BEST among mid-day movers Seeking Alpha - 9/20/2021 1:51:12 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2021 4:18:58 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/13/2021 7:51:58 AM
Edesa Biotech extends EB01 mid-stage dermatitis study to Canada Seeking Alpha - 7/13/2021 9:04:37 AM
Edesa Biotech soars 10% on favorable DSMB review of COVID-19 study Seeking Alpha - 6/18/2021 8:01:25 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/14/2021 9:02:21 AM
Edesa Biotech EPS beats by $0.10 Seeking Alpha - 5/14/2021 8:49:57 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/14/2021 8:03:29 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/26/2021 5:02:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/26/2021 5:00:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/26/2021 4:57:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/26/2021 4:56:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/26/2021 4:54:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/26/2021 4:50:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/26/2021 4:48:32 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 4/23/2021 4:47:05 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/23/2021 4:41:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/26/2021 11:45:15 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/26/2021 11:44:55 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/25/2021 7:19:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/25/2021 6:49:41 PM
Edesa Biotech stock surges after expanding rights to anti-inflammatory technology Seeking Alpha - 3/22/2021 8:24:18 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/22/2021 8:01:03 AM
Gulo   Friday, 09/24/21 04:40:56 PM
Re: None
Post # of 463 
I don't visit ihub much, but came back when EDSA jumped last Monday. I notice there isn't much discussion of the technical viability of the EB05 TLR4 antibody as a treatment for ARDS. So, I hought I'd post this link to an independent review in case anyone cared. In short, TLR4 is looking like a critical checkpoint in ARDS from Covid-19 (as well as other causes). Expect other biotechs to start jumpig on the bandwagon. EDSA is a couple years ahead, and if EBO5 is commercialized, it will be SOC, so it will be hard to recruit for cometing trials.
Review of TLR4 in Covid pathology:
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8095161/


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences